课题基金 / 基金详情

Pre-mRNA Interference of VEGF Pathways in Ocular Angiogenesis

Pre-mRNA Interference of VEGF Pathways in Ocular Angiogenesis
眼部血管生成中 VEGF 通路的前 mRNA 干扰
批准号:
8391552
负责人:
BALAMURALI K AMBATI
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-10-01 至 2013-09-30

项目摘要

项目成果

BALAMURALI K AMBATI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dr. Ambati plans to continue his research into disrupting pathways of new blood vessel formation within cells; this will augment and possibly transcend the current therapies of blockade outside the cell. By using novel techniques to disrupt the gene messaging systems which communicate directions to form new blood vessels, this proposal has the potential of advancing therapies for a variety of blinding conditions, including injury to the cornea (the front part of the eye), diabetes damage to the retina, and macular degeneration. This could translate into improved outcomes for veterans who sustain eye injury and require corneal transplantation (as fighting blood vessel formation is essential to corneal transparency and preventing corneal transplant rejection), as well as improved vision for veterans with diabetic retinopathy and macular degeneration, which are the leading cause of blindness among older veterans. Further, this approach of fighting blood vessel formation by targeting key genetic events within the cell could have major beneficial applications to cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COMP-Ang1: Vascular Normalization and Neuroprotection for Diabetic Retinopathy
  • 批准号:
    9004910
  • 项目类别:
  • 资助金额:
    $33.53万
  • 财政年份:
    2016
  • 负责人:
    BALAMURALI K AMBATI
  • 依托单位:
COMP-Ang1: Vascular Normalization and Neuroprotection for Diabetic Retinopathy
  • 批准号:
    9197294
  • 项目类别:
  • 资助金额:
    $33.53万
  • 财政年份:
    2016
  • 负责人:
    BALAMURALI K AMBATI
  • 依托单位:
Synergistic OEC-biologic Use for Diabetic Retinal Regeneration
Synergistic OEC-biologic Use for Diabetic Retinal Regeneration
海外基金